Biocept (BIOC) Reports Q1 Loss of $0.61

Biocept (NASDAQ: BIOC) reported Q1 EPS of ($0.61), versus ($3.33) reported last year. Revenue for the quarter came in at $976 thousand versus the consensus estimate of $1.43 million.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Fifth Third Bancorp (FITB) Misses Q2 EPS by 1c
• JPMorgan upgrades 3M, Emerson Electric to Overweight ahead of earnings